Search Results 551-560 of 17911 for Pathogens

  1. Neurodegenerative Diseases: Leonard Petrucelli

    Drawing from our mechanistic studies, our lab seeks to identify biological factors that can potentially be used as pathogenic readouts. These factors could ...

  2. COVID-19: The tale of 1 virus and 2 testing methods - Mayo Clinic News Network

    Teams versed in different aspects of laboratory medicine work together to better understand the virus and develop tests to identify those who are infected or ...

  3. Neurodegenerative Diseases: Leonard Petrucelli

    Drawing from our mechanistic studies, our lab seeks to identify biological factors that can potentially be used as pathogenic readouts. These factors could ...

  4. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    Disease symptoms (e.g., diarrhea) caused by a confirmed intestinal pathogen other than C. difficile. Have a current colostomy. Intraabdominal surgery within ...

  5. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Subject has documentation of positive examination for pathogens (ova and parasites, and bacteria), which must have been done in the past 60 days. If ...

  6. A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea - Mayo Clinic

    Had stool studies positive for pathogenic ova and/or parasites;; Have an intolerance or hypersensitivity to daptomycin and/or vancomycin;; Have life ...

  7. A Study To Assess The Effectiveness And Safety Of Pacritinib In Patients With VEXAS Syndrome (PAXIS) - Mayo Clinic

    Documented evidence of a pathogenic or likely pathogenic mutation at M41 or neighboring splice site mutation (c.118-1, c.118-2) position in UBA1 based on ...

  8. Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection - Mayo Clinic

    Stools known to be positive for ova and/or parasite(s), or other enteric pathogens (e.g., Salmonella, Shigella, and/or Campylobacter) within 28 days prior ...

  9. Michael S. Torbenson, M.D. - Mayo Clinic Faculty Profiles

    By inhibiting tumor growth and metastasis, pathogenic infection, receptor signaling, and growth cascades, Dr. Torbenson's work may improve overall survival ...

  10. Publications - Pavel N. Pichurin, M.D. - Mayo Clinic

    Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat Genet. 2021 Jul; 53 (7):1006-1021 Epub 2021 July 01. View PubMed; Klee ...